Category:Statins

**羟甲基戊二酸单酰辅酶A还原酶抑制剂**
	class of drugs used to lower cholesterol levels
	上传媒体
	维基百科
隶属于	药物类别; 一组或一类分子实体;
上级分类	医疗药物; anticholesteremic agents; 酶抑制剂; oxidoreductase inhibitor;
所属实体	response to statin (化学试剂);
规范控制
	Q954845; 美国国会图书馆规范标识符: sh00001691; 捷克国家图书馆标识符: ph602573; BabelNet编号: 00051454n; 以色列国家图书馆标识符: 987007285397905171
	共鸣器; Scholia; Wikidocumentaries; PetScan; 统计学; WikiMap; Locator tool; KML文件; 搜索描述;

子分类

本分类只有以下子分类。

H

HMG-CoA reductase inhibitors‎ (9 C, 24 F)

分类“Statins”中的媒体文件

以下40个文件属于本分类，共40个文件。

Advlip.jpg 911 × 615；51 KB
Algorithm for statin-associated myopathy.jpg 810 × 900；88 KB
Biosynthesis-dielsalder.png 1,523 × 1,602；77 KB
Biosynthesis-lovd.png 1,442 × 1,177；60 KB
Cholesterolbiosynthesis.png 1,930 × 2,427；40 KB
Differential-epigenetic-reprogramming-in-response-to-specific-endocrine-therapies-promotes-ncomms10044-s2.ogv 20秒, 1,344 × 1,024；15.49 MB
Differential-epigenetic-reprogramming-in-response-to-specific-endocrine-therapies-promotes-ncomms10044-s3.ogv 20秒, 1,344 × 1,024；12.31 MB
Differential-epigenetic-reprogramming-in-response-to-specific-endocrine-therapies-promotes-ncomms10044-s4.ogv 20秒, 1,344 × 1,024；10.26 MB
Differential-epigenetic-reprogramming-in-response-to-specific-endocrine-therapies-promotes-ncomms10044-s5.ogv 19秒, 1,344 × 1,024；18.75 MB
Differential-epigenetic-reprogramming-in-response-to-specific-endocrine-therapies-promotes-ncomms10044-s6.ogv 13秒, 1,344 × 1,024；10.5 MB
Differential-epigenetic-reprogramming-in-response-to-specific-endocrine-therapies-promotes-ncomms10044-s7.ogv 13秒, 1,344 × 1,024；9 MB
Differential-epigenetic-reprogramming-in-response-to-specific-endocrine-therapies-promotes-ncomms10044-s8.ogv 13秒, 1,344 × 1,024；10.57 MB
Differential-epigenetic-reprogramming-in-response-to-specific-endocrine-therapies-promotes-ncomms10044-s9.ogv 13秒, 1,344 × 1,024；8.86 MB
Estatina final.png 315 × 209；13 KB
Estatina.png 578 × 174；17 KB
Fluvastatina Grupo fluorofenil.jpg 468 × 311；26 KB
HMG-CoA reductase pathway.svg 500 × 911；16 KB
Metabolic pathway of a typical statin.png 4,762 × 4,757；221 KB
Metabolizm i eliminacja statyn oraz potencjalne mechanizmy ich interakcji lekowych 2013.png 3,345 × 1,965；534 KB
Ogólny mechanizm plejotropowego działania statyn.png 3,507 × 2,480；403 KB
Schematyczna budowa cząsteczki statyn.png 4,877 × 2,170；109 KB
Statin final.svg 210 × 139；14 KB
Statin mechanism v01.svg 652 × 282；65 KB
Statin pharmacophore 2.png 3,787 × 2,861；63 KB
Statin pharmacophore.png 665 × 614；7 KB
Statin pharmacophore.svg 162 × 142；10 KB
Statin Risks (6941350219).jpg 2,784 × 2,702；1.08 MB
Statin-Test.png 838 × 759；66 KB
Statin.svg 385 × 116；17 KB
Statinfamily.png 1,144 × 315；48 KB
StatinPathway WP430.png 828 × 743；62 KB
Statins-1.generation v01.svg 988 × 476；103 KB
Statins77.png 516 × 461；38 KB
Vectorial pathway for statin distribution from enterocytes to hepatocytes for their pharmacological action and metabolism and elimination via the bile and kidneys.png 3,654 × 2,375；697 KB
Wpływ fluwastatyny na wskaźniki lipidowe 01.png 1,747 × 1,900；69 KB
Wpływ fluwastatyny na wskaźniki lipidowe 02.png 1,747 × 1,891；46 KB
Wpływ fluwastatyny na wskaźniki lipidowe 03.png 1,751 × 1,900；78 KB
Wpływ prawastatyny na wskaźniki lipidowe 01.png 1,747 × 1,900；75 KB
Wpływ prawastatyny na wskaźniki lipidowe 02.png 1,747 × 1,891；77 KB
Wpływ prawastatyny na wskaźniki lipidowe 03.png 1,755 × 1,900；82 KB

Category:Statins

子分类

H

分类“Statins”中的媒体文件

导航菜单

搜索